News search
 Research 7 Nov 2022 A CNIC study reveals that mutations previously identified in the gene MINDBOMB1 (MIB1) as causing non-compaction cardiomyopathy either provoke this disease or valve defects, depending on their combination with mutations in modifier genes |
 About the CNIC 2 Nov 2022 A new study defines a mechanism that regulates inflammation after a myocardial infarction, opening a path to the use of the receptor |
 Research 3 Oct 2022 Metoprolol, an established drug in the cardiologists armory, protects the brain during a stroke and greatly reduces its consequences |
 About the CNIC 19 Sep 2022 CNIC's leader have been recognized for his exceptional career achievements at the 34th annual conference |
 Research 12 Sep 2022 The findings, published in the Journal of the American College of Cardiology (JACC), will enable physicians to make appropriate treatment adjustments for patients with this disease |
 Research 29 Aug 2022 The findings, published in the Journal of the American College of Cardiology (JACC), represent a first step towards the personalized treatment of patients with this disease |
 Research 26 Aug 2022 The results of the SECURE trial, coordinated by CNIC were presented in a Hot Line session at the European Society of Cardiology meeting (ESC 2022) in Barcelona and published at the NEJM |
 About the CNIC 23 Aug 2022 The finding provides a basis for mitigating the loss of muscle regenerative capacity in elderly people |
 Research 9 Aug 2022 A new study published in eLife shows that inhibition of p38γ/δ is a potential therapeutic strategy for the treatment of hypertrophic cardiomyopathy, but that this strategy has yet to be explored because of the lack of specific inhibitors for these p38 family members |
 About the CNIC 9 Aug 2022 Dr. Amelia Escolano runs her own group in Philadelphia (USA) where she is an Assistant Professor at the Wistar Institute's Center for Vaccines and Immunotherapy |
- 1 of 25
- next ›
